Related Experiment Video
Updated: Mar 17, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.7K
Cationic Lipid-Coated Polyplexes (Lipopolyplexes) for DNA and Small RNA Delivery
1Rudolf-Boehm-Institute for Pharmacology and Toxicology, Clinical Pharmacology, Härtelstrasse 16-18, 04107, Leipzig, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|July 21, 2016
Summary
This study details optimal lipopolyplex formulations for nucleic acid (NA) delivery, enhancing gene therapy potential. These advanced lipopolyplexes show stability and efficacy for in vivo applications.
Area of Science:
- Biotechnology
- Nanomedicine
- Gene Therapy
Background:
- Nonviral gene delivery vectors like liposomes and cationic polymers are crucial for nucleic acid (NA) delivery.
- Polyethylenimines (PEIs) are established NA delivery platforms, forming polyplexes.
- Combining PEIs with liposomes creates lipopolyplexes, enhancing efficacy and biocompatibility.
Purpose of the Study:
- To define optimal lipopolyplex compositions and generation parameters.
- To explore combinations of various liposomes and PEIs (branched/linear, low-molecular weight).
- To identify ideal N/P ratios, lipid types, and lipid/PEI ratios.
Main Methods:
- Systematic variation of liposome and PEI components.
- Optimization of preparation conditions and formulation parameters.
- Assessment of lipopolyplex physicochemical properties and biological activity.
Main Results:
- Optimal lipopolyplex compositions were identified for effective NA delivery.
- Specific formulations demonstrated retained biological activity and integrity.
- Stability was confirmed under various conditions, including storage, serum presence, and nebulization.
Conclusions:
- Lipopolyplexes offer a promising platform for advanced nucleic acid delivery.
- Optimized formulations exhibit enhanced stability and biocompatibility for in vivo use.
- These findings support the translation of lipopolyplex technology to diverse therapeutic applications.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82
02:30siRNA - Small Interfering RNAs
19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
01:23RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K